# 2025-04106: FDA Pulls Plug on Eight Unused Generic Drugs

2025-04106, Bausch & Lomb Incorporated, et al.; Withdrawal of Approval of Eight Abbreviated New Drug Applications, is a Federal Register notice from Health and Human Services Department, Food and Drug Administration published 2025-03-14, effective 2025-04-14; PRIA reads it as touching household money (as of 2026-09-30).

- Canonical: https://policyrisk.com/federal-register/2025-04106
- As of: 2026-09-30
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2025-04106
- Title: Bausch & Lomb Incorporated, et al.; Withdrawal of Approval of Eight Abbreviated New Drug Applications
- Type: Notice
- Agencies: Health and Human Services Department; Food and Drug Administration
- Citation: 90 FR 12163
- Published: 2025-03-14
- Effective: 2025-04-14
- Comments close: not stated
- Significant: no
- Touches household money: yes
- Regulation identifier numbers: none
- Last updated: 2026-09-30

## In one line

FDA Pulls Plug on Eight Unused Generic Drugs

## Summary

The FDA is officially pulling the plug on eight drug approvals because the companies stopped selling these medicines. This change kicks in on April 14, 2025, but companies can apply again if they want. Patients and pharmacies using these drugs should check for alternatives soon to avoid any hiccups.

## Abstract

The Food and Drug Administration (FDA or Agency) is withdrawing approval of eight abbreviated new drug applications (ANDAs) from multiple applicants. The applicants notified the Agency in writing that the drug products were no longer marketed and requested that the approval of the applications be withdrawn.

## Effects PRIA read

- Eight drug approvals withdrawn April 14, 2025: cost, medium. The FDA is withdrawing approval of eight abbreviated new drug applications as of April 14, 2025. The affected products are: ACETIC ACID 2% in aqueous aluminum acetate solution/drop; ERYTHROCIN STEARATE (erythromycin stearate) tablets (EQ 125 mg, EQ 250 mg, EQ 500 mg base); Levobunolol HCl solution/…
- Existing inventory may still be dispensed: benefit, low. Drug products listed in the withdrawal table that are in inventory on April 14, 2025 may continue to be dispensed until inventories are depleted, until the products reach their expiration dates, or until they otherwise become violative—whichever occurs first. Pharmacies and other holders of on-hand…

## Related documents

- [2026-20848](https://policyrisk.com/federal-register/2026-20848): Use of Salt Substitutes To Reduce the Sodium Content in Standardized Foods, 2026-10-13
- [2026-16296](https://policyrisk.com/federal-register/2026-16296): Substances Generally Recognized as Safe, 2026-08-11
- [2026-14073](https://policyrisk.com/federal-register/2026-14073): Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign E…, 2026-07-13
- [2026-13047](https://policyrisk.com/federal-register/2026-13047): Establishment Registration and Product Listing for Tobacco Products, 2026-06-29
- [2025-04978](https://policyrisk.com/federal-register/2025-04978): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-03-25
- [2025-01840](https://policyrisk.com/federal-register/2025-01840): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-01-27

## Sources
- [2025-04106 on federalregister.gov](https://www.federalregister.gov/documents/2025/03/14/2025-04106/bausch-and-lomb-incorporated-et-al-withdrawal-of-approval-of-eight-abbreviated-new-drug-applications)
- [2025-04106 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2025-03-14/pdf/2025-04106.pdf)

## Related
- [Previous: 2025-04101, Sage Therapeutics, Inc.; Withdrawal of Approval of a New Drug Application for Z…](https://policyrisk.com/federal-register/2025-04101)
- [Next: 2025-04107, Bausch & Lomb Incorporated, et al.; Withdrawal of Approval of Four Abbreviated…](https://policyrisk.com/federal-register/2025-04107)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2025-04106 (as of 2026-09-30).
